Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

128
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
128

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Insilico study to unveil the characteristics of pseudoRab GTPases in pathogenic protozoan parasites: <i>Entamoeba histolytica</i>.

In silico pharmacology·2026
Same author

Food Service Directors' Knowledge and Beliefs About Ultraprocessed Foods in California's San Joaquin Valley Schools.

Preventing chronic disease·2026
Same author

Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches.

Frontiers in pharmacology·2026
Same author

Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.

Biochemical pharmacology·2026
Same author

Risk Factors for Early Chronic Kidney Disease IV-V in Children with Posterior Urethral Valves: A Retrospective Cohort Study.

Journal of Indian Association of Pediatric Surgeons·2026
Same author

Nitrogen-Doped Carbon Quantum Dots for FRET-Assisted and Smartphone-Enabled Fluorescent Detection of Melatonin in Biological Samples.

Journal of fluorescence·2026

相关实验视频

Updated: Jun 18, 2025

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.4K

败血症中的生物标志物

Juhi Saxena1, Sarvjeet Das2, Anshu Kumar2

  • 1Department of Biotechnology, Parul Institute of Technology, Parul University, Vadodara, Gujarat, India.

Clinica chimica acta; international journal of clinical chemistry
|July 27, 2024
PubMed
概括

生物标志物对于诊断败血症至关重要,这是危及生命的感染反应. 本综述涵盖了早期检测,风险评估和指导抗微生物药物管理的既定和新兴生物标志物,以改善患者的生存率.

关键词:
抗微生物药物管理管理生物标志物 生物标志物诊断 诊断 诊断 诊断 诊断风险分层是指风险的分层.败血症 这是一种败血症.转录诊断的诊断方法

更多相关视频

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

163
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.7K

相关实验视频

Last Updated: Jun 18, 2025

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
05:28

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

3.4K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

163
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.7K

科学领域:

  • 关键护理医学 关键护理医学
  • 传染病 传染病 传染病
  • 生物标志物研究的研究.

背景情况:

  • 败血症是感染导致的危及生命的器官功能障碍,导致全球显著的死亡率.
  • 及时诊断和治疗对于改善败血症患者生存率至关重要.
  • 生物标志物是败血症诊断,风险分层和管理的重要工具.

研究的目的:

  • 审查目前和新兴的生物标志物用于败血症诊断和管理.
  • 探索生物标志物在抗菌药物管理和风险评估中的应用.
  • 讨论转录诊断和败血症的元基因组测序方面的进展.

主要方法:

  • 关于败血症生物标志物的综合文献综述.
  • 分析各种生物标志物的诊断和预后值.
  • 探索新的方法,如转录诊断和元基因组学.

主要成果:

  • 已建立的生物标志物 (WBC,CRP,IL-6,PCT) 显示出诊断和预后效用.
  • 生物标志物有助于指导抗微生物治疗和患者风险分层.
  • 新兴技术为宿主反应和微生物识别提供了更深入的见解.

结论:

  • 基于生物标志物的策略对于有效的败血症诊断和管理至关重要.
  • 由生物标志物指导的个性化治疗可以改善临床结果.
  • 未来的研究应该专注于整合新的诊断工具来治疗败血症.